Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling

Abstract

Long non-coding RNA THOR (Lnc-THOR) binds to IGF2BP1, essential for its function. We here show that Lnc-THOR is expressed in human glioma tissues and cells. Its expression is extremely low or even undetected in normal brain tissues, as well as in human neuronal cells and astrocytes. We show that Lnc-THOR directly binds to IGF2BP1 in established and primary human glioma cells. shRNA-mediated Lnc-THOR knockdown or CRISPR/Cas9-induced Lnc-THOR knockout potently inhibited cell survival and proliferation, while provoking glioma cell apoptosis. Contrarily, forced overexpression of Lnc-THOR promoted glioma cell growth and migration. Importantly, Lnc-THOR shRNA or knockout activated MAGEA6-AMPK signaling in glioma cells. AMPK inactivation, by AMPKα1 shRNA, knockout, or dominant-negative mutation (T172A), attenuated Lnc-THOR shRNA-induced A172 glioma cell apoptosis. Moreover, CRISPR/Cas9-induced IGF2BP1 knockout activated MAGEA6-AMPK signaling as well, causing A172 glioma cell apoptosis. Significantly, Lnc-THOR shRNA was ineffective in IGF2BP1 KO A172 cells. In vivo, Lnc-THOR silencing or knockout potently inhibited subcutaneous A172 xenograft tumor growth in mice. MAGEA6 downregulation and AMPK activation were detected in Lnc-THOR-silenced/-KO A172 tumor tissues. Taken together, Lnc-THOR depletion inhibits human glioma cell survival possibly by activating MAGEA6-AMPK signaling.

Four-octyl itaconate activates Nrf2 cascade to protect osteoblasts from hydrogen peroxide-induced oxidative injury

“…Following treatment, the total cellular RNA was extracted by TRIzol reagents 21 . The qPCR procedures using a SYBR Green PCR kit (Applied Biosystems, Suzhou, China) under the ABI Prism7500 Fast Real-Time PCR system were reported before 22 .…”

Long Non-Coding RNA THOR Enhances the Stem Cell-Like Traits of Triple-Negative Breast Cancer Cells Through Activating β-Catenin Signaling

“…Notably, as shown in Figures 4C and 5B , the mobility shift of β-catenin was also affected by ectopic expression of THOR in TNBC cells. This could be due to the fact that THOR knockdown suppresses the expression of some kinases which can phosphorylate β-catenin, such as AMPK signaling [ 27 ], AKT signaling [ 18 ], and ERK signaling [ 28 ], and thus decreases the phosphorylation level of β-catenin and increases the mobility shift of β-catenin. Other possible reasons that THOR knockdown increases the expression of some splicing factors which could excise β-catenin protein, resulting in an excised β-catenin protein, should be further explored in the future.…”

miR-107 inhibition upregulates CAB39 and activates AMPK-Nrf2 signaling to protect osteoblasts from dexamethasone-induced oxidative injury and cytotoxicity

“…Second, the AMPKα1 shRNA lentiviral particles were added to OB-6 osteoblastic cells, resulting in significant AMPKα1 downregulation ("sh-AMPKα1", Figure 3E). Furthermore the CRISPR-Cas-9 strategy [32] was applied to knockout AMPKα1 in OB-6 cells ("ko-AMPKα1", Figure 3E). As demonstrated, antagomiR-107-induced AMPK activation was largely inhibited in OB-6 cells with dn-AMPKα1, sh-AMPKα1 or ko-AMPKα1.…”

“…The CRISPR/Cas9 AMPKα1-KO construct (from Dr. Pan at Shanghai Jiao Tong University [32]) was transfected to OB-6 cells via Lipofectamine 2000, with stable cells selected by puromycin. AMPKα1 KO in stable cells was confirmed by Western blotting.…”